Lentitek logo

Lentitek

Enabling the next generation of medicines

9 employees · est. 2019 · Edinburgh, United Kingdom

VS
NewBiologix logo

NewBiologix

Developing technologies for the biopharma industry to allow them to treat the root causes of diseases and disorders.

25 employees · est. 2023 · Epalinges, Switzerland

Lentitek is the older company (2019 vs 2023); NewBiologix is the larger of the two.

Side-by-Side Comparison

Lentitek NewBiologix
Founded
2019 older 2023
Headquarters
Edinburgh, United Kingdom Epalinges, Switzerland
Employees
9 25 larger
Industry
Biotechnology, Health Care Biotechnology, Health Care, Life Sciences
Funding Stage
Seed Series A
Total Funding
$1.15M $45.00M
Funding Rounds
3 1
Services
Lentivirus vector quality enhancement, Increase in vector yield, Scalable production solutions, Integrable vector manufacturing processes Xcell™ Genomic Analytical Platform, Xcell™ Eng-HEK293 Cell Line, Xcell™ rAAV Production and Analytics Platform
Target Customers
Biotech companies, Pharmaceutical companies, Gene therapy firms, Research labs, Healthcare institutions Biopharmaceutical Companies, Gene Therapy Researchers, Biotech Entrepreneurs, Healthcare Innovators
Taxonomy
Cell Therapy, Gene Therapy, Viral Vector, Production Yield, Pharmaceuticals, Gene-modified Cell Therapies, CAR-T, Therapeutic Solutions DNA Integration, Gene Therapy, Cell Therapy, Viral Vectors, Genomic Integration, Biopharma Technology, Advanced Cell Engineering, RAAV, Biologics, Stable Cell Lines, Mammalian Cell Lines, Gene Expression, Capsid Optimization, Bioinformatics, Transcriptomics
Website
lentitek.com newbiologix.com
Lentitek logo

About Lentitek

Lentitek, founded in 2019 and headquartered in the United Kingdom, operates at the intersection of Biotechnology and Health Care. Their mission is captured by their slogan: "Enabling the next generation of medicines." The company addresses a critical bottleneck within the field of gene and gene-mod...

NewBiologix logo

About NewBiologix

NewBiologix, founded in 2023 and headquartered in Lausanne, Switzerland, is positioning itself as a significant contender in the Biotechnology, Health Care, and Life Sciences sectors. The company's mission, encapsulated in their slogan, "Developing technologies for the biopharma industry to allow th...

We will tell you when either one moves

BounceWatch watches Lentitek and NewBiologix for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Lentitek and NewBiologix — by email.

Frequently Asked Questions

Lentitek — Enabling the next generation of medicines. NewBiologix — Developing technologies for the biopharma industry to allow them to treat the root causes of diseases and disorders.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Lentitek has raised $1.15M while NewBiologix has raised $45.00M.
Lentitek and NewBiologix operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Lentitek with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Lentitek on 12 Sep 2024, and NewBiologix on 25 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes